Search for: "In Re Mdl"
Results 321 - 340
of 1,536
Sort by Relevance
|
Sort by Date
24 Mar 2016, 5:32 am
”) (citations omitted); In re Cellular Telephones, 2014 WL 7793690, at *9 (Mag. [read post]
9 Mar 2016, 5:00 am
That part we’re keeping to ourselves, unless you’re a paying client. [read post]
8 Mar 2016, 5:00 am
The plaintiff(s) may end up re-filing somewhere with personal jurisdiction, but dismissal is clearly a setback. [read post]
7 Mar 2016, 3:32 pm
(Cook Medical, Inc., IVC Filters Marketing, Sales Practices and Products Liability Litigation – MDL 2570; In Re: Bard IVC Filters Products Liability Litigation – MDL No. 2641). [read post]
3 Mar 2016, 1:05 pm
In re Takata Airbag Prods. [read post]
26 Feb 2016, 10:48 am
In In re Avandia Marketing & Sales Practices and Product Liability Litigation, No. 15-2145, 2016 WL 559216 (3d Cir. [read post]
26 Feb 2016, 7:25 am
In December of 2015, an article was published in the British Medical Journal regarding the need to re-analyze the ROCKET AF data due to the use of an alleged faulty testing device. [read post]
25 Feb 2016, 2:39 pm
In In re Avandia Marketing, Sales Practices and Products Liability Litigation (Linda and John Schatz, appellants), -- Fed. [read post]
19 Feb 2016, 1:30 pm
As for what little has happened since then concerning this proposed Viagra MDL case, we turn to this January 4, 2016 news report, "JPMDL Won’t Expedite Hearing On Viagra Skin Cancer MDL Motion": The Judicial Panel on Multidistrict Litigation (JPMDL) on Dec. 29 denied a joint request by Pfizer Inc. and Viagra plaintiffs to place a motion for a skin cancer multidistrict litigation on the panel’s Jan. 28 agenda (In Re: Viagra Products Liability… [read post]
9 Feb 2016, 6:27 am
In re Paxil Litigation, 2002 WL 1940708 (C.D. [read post]
5 Feb 2016, 7:55 am
Batty at *10, citing In Re Zoloft, 26 F. [read post]
3 Feb 2016, 10:50 am
The case is In Re Ethicon Inc. [read post]
3 Feb 2016, 4:30 am
If two million documents are produced in an MDL, fewer than 200 are likely ever to be marked as exhibits at trial. [read post]
1 Feb 2016, 8:29 am
In In re Xarelto (Rivaroxaban) Products Liability Litigation, 2016 WL 311762 (E.D. [read post]
1 Jan 2016, 7:08 am
While this “stop selling” or “never sell” theory has been labeled in various ways (including “fraud on the FDA”) to meet the plaintiff’s particular needs, it seems to us like a re-framing of design defect, albeit without pesky requirements like a feasible alternative design, no liability with adequate (or without inadequate) warnings, or proximate cause. [read post]
31 Dec 2015, 9:30 am
The last day of 2015 is upon us, and we’re wrapping up the year with our December installment of Stem client news. [read post]
31 Dec 2015, 5:30 am
In re: Target Corporation Customer MDL, No. 14-2522 (D. [read post]
31 Dec 2015, 5:12 am
Full disclosure: Reed Smith is involved in Caplinger, so consider this entry a non-RS post.In re Celexa & Lexapro Marketing & Sales Practices Litigation, 779 F.3d 34 (1st Cir. 2015). [read post]
30 Dec 2015, 7:28 pm
As we store away the wrapping paper and pull out the New Years’ hat and horns, we thought it would be a good time to review the significant agricultural law developments of 2015. [read post]
24 Dec 2015, 8:20 am
The legislature chose not to punish FDA-regulated activity, but the court nullified that legislative decision, with practically no discussion.In re Avandia Marketing, Sales Practices & Product Liability Litigation, 804 F.3d 633 (3d Cir. 2015). [read post]
